Largest pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Viatris has the lowest figure of the 61 pharmaceutical companies ranked by earnings, at -AED 12.9B, followed by Insmed (-AED 4.7B) and Summit Therapeutics (-AED 4B). Figures as of 18 Nov 2026, 17:48 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Viatris-AED 12.9B
- Median
- AED 216.7M
- Combined market value
- AED 18.69T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ViatrisVTRS · Health Care | -AED 12.9B | AED 87.3B | AED 76.16 | 1.39% up | 96% up | ||
| 2 | InsmedINSM · Health Care | -AED 4.7B | AED 97.5B | AED 444.26 | 0.74% down | 40% down | ||
| 3 | Summit TherapeuticsSMMT · Health Care | -AED 4B | AED 31.3B | AED 39.15 | 0.09% down | 36% down | ||
| 4 | Takeda PharmaceuticalTAK · Health Care | -AED 3.5B | AED 251B | AED 78.56 | 1.16% down | 54% up | ||
| 5 | CytokineticsCYTK · Health Care | -AED 2.9B | AED 26.4B | AED 189.68 | 0.01% down | 20% down | ||
| 6 | BridgeBio PharmaBBIO · Health Care | -AED 2.7B | AED 55.7B | AED 286.18 | 1.46% up | 17% up | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | -AED 1.4B | AED 16.9B | AED 101.33 | 2.34% up | 64% down | ||
| 8 | ABIVAXABVX · Health Care | -AED 1.4B | AED 27B | AED 308.55 | 2.33% up | 27% down | ||
| 9 | Jazz PharmaceuticalsJAZZ · Health Care | -AED 1.3B | AED 58.1B | AED 905.12 | 2.38% up | 37% up | ||
| 10 | Cogent BiosciencesCOGT · Health Care | -AED 1.2B | AED 18.1B | AED 103.76 | 1.44% up | 20% down | ||
| 11 | Praxis Precision MedicinesPRAX · Health Care | -AED 1.1B | AED 31.7B | AED 1,133.26 | 1.15% up | 61% up | ||
| 12 | Roivant SciencesROIV · Health Care | -AED 1.1B | AED 102.9B | AED 142.01 | 0.12% down | 90% up | ||
| 13 | Legend BiotechLEGN · Health Care | -AED 1.1B | AED 11.5B | AED 59.54 | 0.62% up | 42% down | ||
| 14 | Madrigal PharmaceuticalsMDGL · Health Care | -AED 1.1B | AED 34.7B | AED 1,493.25 | 3.65% down | 24% down | ||
| 15 | Ascendis PharmaASND · Health Care | -AED 929.2M | AED 65.4B | AED 997.42 | 0.14% up | 28% up | ||
| 16 | Elanco Animal HealthELAN · Health Care | -AED 852.1M | AED 49.2B | AED 98.47 | 3.71% up | 20% up | ||
| 17 | Rhythm PharmaceuticalsRYTM · Health Care | -AED 721.8M | AED 30.3B | AED 437.43 | 2.14% up | 13% up | ||
| 18 | Definium TherapeuticsDFTX · Health Care | -AED 675M | AED 14.6B | AED 106.73 | 1.09% down | 169% up | ||
| 19 | Axsome TherapeuticsAXSM · Health Care | -AED 672.8M | AED 25.8B | AED 491.11 | 1.64% down | 7% down | ||
| 20 | Edgewise TherapeuticsEWTX · Health Care | -AED 616.3M | AED 16.8B | AED 153.78 | 0.40% down | 88% up | ||
| 21 | Dianthus TherapeuticsDNTH · Health Care | -AED 596.2M | AED 18B | AED 320.45 | 0.31% up | 113% up | ||
| 22 | Spyre TherapeuticsSYRE · Health Care | -AED 570M | AED 34B | AED 357.79 | 3.84% up | 286% up | ||
| 23 | Protagonist TherapeuticsPTGX · Health Care | -AED 478M | AED 30.1B | AED 460.64 | 0.60% up | 46% up | ||
| 24 | ErascaERAS · Health Care | -AED 457.4M | AED 17.2B | AED 48.88 | 4.18% down | 403% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -AED 387.2M | AED 24.4B | AED 359.20 | 1.54% up | 241% up | ||
| 26 | Belite BioBLTE · Health Care | -AED 285M | AED 23.6B | AED 581.88 | 0.45% up | 31% up | ||
| 27 | VeradermicsMANE · Health Care | -AED 257.1M | AED 19.2B | AED 455.39 | 1.31% down | 233% up | ||
| 28 | Travere TherapeuticsTVTX · Health Care | -AED 93.8M | AED 18.1B | AED 188.16 | 0.25% up | 44% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | -AED 85.8M | AED 22.1B | AED 338.23 | 0.15% up | 31% up | ||
| 30 | Arrowhead PharmaceuticalsARWR · Health Care | -AED 6M | AED 22.6B | AED 159.86 | 1.24% up | 10% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | AED 216.7M | AED 27.6B | AED 350.84 | 0.44% up | 126% up | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | AED 264.7M | AED 28.1B | AED 80.65 | 3.98% up | 83% up | ||
| 33 | Corcept TherapeuticsCORT · Health Care | AED 366M | AED 27.5B | AED 251.05 | 2.45% down | 8% down | ||
| 34 | Ligand PharmaceuticalsLGND · Health Care | AED 457.1M | AED 22.1B | AED 1,104.45 | 2.35% up | 43% up | ||
| 35 | AlkermesALKS · Health Care | AED 887.6M | AED 28.9B | AED 171.96 | 3.01% up | 58% up | ||
| 36 | BeOne MedicinesONC · Health Care | AED 1.1B | AED 170.1B | AED 1,489.54 | 1.86% down | 17% up | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | AED 1.2B | AED 74.8B | AED 558.71 | 2.80% down | 66% down | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | AED 1.3B | AED 43.1B | AED 222.70 | 3.63% up | 11% up | ||
| 39 | GrifolsGRFS · Health Care | AED 1.6B | AED 21.2B | AED 31.09 | 1.91% down | 1% up | ||
| 40 | TG TherapeuticsTGTX · Health Care | AED 1.6B | AED 36.8B | AED 243.23 | 5.61% up | 107% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | AED 1.7B | AED 46B | AED 55.15 | 1.52% up | 5% up | ||
| 42 | PTC TherapeuticsPTCT · Health Care | AED 2.5B | AED 18.6B | AED 222.09 | 0.18% up | 20% down | ||
| 43 | Royalty PharmaRPRX · Health Care | AED 2.8B | AED 146.3B | AED 254.53 | 0.90% up | 78% up | ||
| 44 | GenmabGMAB · Health Care | AED 3.5B | AED 116.6B | AED 189.15 | 0.89% down | 70% up | ||
| 45 | United TherapeuticsUTHR · Health Care | AED 4.9B | AED 90.9B | AED 2,133.93 | 0.53% down | 23% up | ||
| 46 | Teva Pharmaceutical IndustriesTEVA · Health Care | AED 5.2B | AED 181B | AED 155.14 | 0.89% down | 74% up | ||
| 47 | ZoetisZTS · Health Care | AED 9.8B | AED 126.6B | AED 311.51 | 1.60% up | 29% down | ||
| 48 | Vertex PharmaceuticalsVRTX · Health Care | AED 14.5B | AED 499.1B | AED 1,968.40 | 0.33% up | 27% up | ||
| 49 | AbbVieABBV · Health Care | AED 15.5B | AED 1.87T | AED 1,057.07 | 1.71% down | 26% up | ||
| 50 | Regeneron PharmaceuticalsREGN · Health Care | AED 16.5B | AED 360.7B | AED 3,486.37 | 0.89% down | 36% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | AED 24B | AED 665.2B | AED 384.06 | 0.13% down | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | AED 25.9B | AED 450.6B | AED 220.42 | 2.18% down | 34% up | ||
| 53 | GSKGSK · Health Care | AED 27.9B | AED 359.2B | AED 179.20 | 0.91% down | 6% up | ||
| 54 | PfizerPFE · Health Care | AED 28.5B | AED 589.6B | AED 103.44 | 1.07% down | 14% up | ||
| 55 | SanofiSNY · Health Care | AED 31.8B | AED 417.2B | AED 173.74 | 0.47% down | 4% down | ||
| 56 | AstraZenecaAZN · Health Care | AED 37.6B | AED 1.02T | AED 658.98 | 1.56% down | 2% up | ||
| 57 | NovartisNVS · Health Care | AED 51.4B | AED 1.08T | AED 572.88 | 1.98% down | 25% up | ||
| 58 | Novo NordiskNVO · Health Care | AED 55.8B | AED 641.1B | AED 145.47 | 2.69% down | 17% down | ||
| 59 | Merck & CoMRK · Health Care | AED 67B | AED 1.26T | AED 509.78 | 3.19% down | 51% up | ||
| 60 | Eli LillyLLY · Health Care | AED 75.8B | AED 4.55T | AED 5,104.18 | 1.82% down | 35% up | ||
| 61 | Johnson & JohnsonJNJ · Health Care | AED 98.4B | AED 2.44T | AED 1,014.08 | 0.93% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6728 AED).
Questions and answers
Which pharmaceutical companies have the lowest earnings?
Viatris (-AED 12.9B), Insmed (-AED 4.7B) and Summit Therapeutics (-AED 4B) have the lowest earnings of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 17:48 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by earnings have a combined market value of AED 18.69T as of 18 Nov 2026, 17:48 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.